Investigation of HLA class I downregulation in breast cancer by RT-PCR (Q73448037)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Investigation of HLA class I downregulation in breast cancer by RT-PCR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

G L Palmisano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M P Pistillo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Capanni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Pera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Nicolò

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Salvi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Perdelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Pasciucco

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G B Ferrara

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

133-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

HLA and cancer: from research to clinical impact

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Mechanisms of loss of HLA class I expression on colorectal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Genes regulating MHC class I processing of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Altered MHC class I antigens in tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Biochemical analysis of HLA class I subunits expression in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

The HLA crossroad in tumor immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Decreased HLA-A expression in prostate cancer is associated with normal allele dosage in the majority of cases

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

Antigen presentation by MHC class I and its regulation by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900241-X

7 January 2021

10.1016/S0198-8859(00)00241-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182222%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference